Literature DB >> 27053768

Behavioural activation system sensitivity is associated with cerebral μ-opioid receptor availability.

Tomi Karjalainen1, Lauri Tuominen2, Sandra Manninen3, Kari K Kalliokoski3, Pirjo Nuutila4, Iiro P Jääskeläinen5, Riitta Hari6, Mikko Sams5, Lauri Nummenmaa7.   

Abstract

The reinforcement-sensitivity theory proposes that behavioural activation and inhibition systems (BAS and BIS, respectively) guide approach and avoidance behaviour in potentially rewarding and punishing situations. Their baseline activity presumably explains individual differences in behavioural dispositions when a person encounters signals of reward and harm. Yet, neurochemical bases of BAS and BIS have remained poorly understood. Here we used in vivo positron emission tomography with a µ-opioid receptor (MOR) specific ligand [(11)C]carfentanil to test whether individual differences in MOR availability would be associated with BAS or BIS. We scanned 49 healthy subjects and measured their BAS and BIS sensitivities using the BIS/BAS scales. BAS but not BIS sensitivity was positively associated with MOR availability in frontal cortex, amygdala, ventral striatum, brainstem, cingulate cortex and insula. Strongest associations were observed for the BAS subscale 'Fun Seeking'. Our results suggest that endogenous opioid system underlies BAS, and that differences in MOR availability could explain inter-individual differences in reward seeking behaviour.
© The Author (2016). Published by Oxford University Press. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  BAS; BIS; PET; carfentanil; opioid

Mesh:

Substances:

Year:  2016        PMID: 27053768      PMCID: PMC4967806          DOI: 10.1093/scan/nsw044

Source DB:  PubMed          Journal:  Soc Cogn Affect Neurosci        ISSN: 1749-5016            Impact factor:   3.436


  52 in total

Review 1.  State-dependent opioid control of pain.

Authors:  Howard Fields
Journal:  Nat Rev Neurosci       Date:  2004-07       Impact factor: 34.870

2.  Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

Authors:  Ying Zhang; Danxin Wang; Andrew D Johnson; Audrey C Papp; Wolfgang Sadée
Journal:  J Biol Chem       Date:  2005-07-26       Impact factor: 5.157

3.  Adult attachment style is associated with cerebral μ-opioid receptor availability in humans.

Authors:  Lauri Nummenmaa; Sandra Manninen; Lauri Tuominen; Jussi Hirvonen; Kari K Kalliokoski; Pirjo Nuutila; Iiro P Jääskeläinen; Riitta Hari; Robin I M Dunbar; Mikko Sams
Journal:  Hum Brain Mapp       Date:  2015-06-05       Impact factor: 5.038

4.  Bayesian image reconstruction for emission tomography based on median root prior.

Authors:  S Alenius; U Ruotsalainen
Journal:  Eur J Nucl Med       Date:  1997-03

Review 5.  Understanding opioid reward.

Authors:  Howard L Fields; Elyssa B Margolis
Journal:  Trends Neurosci       Date:  2015-01-29       Impact factor: 13.837

6.  Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.

Authors:  Nora Hagelberg; Sargo Aalto; Lauri Tuominen; Ullamari Pesonen; Kjell Någren; Jarmo Hietala; Harry Scheinin; Antti Pertovaara; Ilkka K Martikainen
Journal:  Neurosci Lett       Date:  2012-05-20       Impact factor: 3.046

7.  An examination of the relationship between behavioral approach system (BAS) sensitivity and social interaction anxiety.

Authors:  Nathan A Kimbrel; John T Mitchell; Rosemery O Nelson-Gray
Journal:  J Anxiety Disord       Date:  2010-02-12

8.  Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo.

Authors:  Vikram Rajashekara; Chintan N Patel; Kaushal Patel; Vishal Purohit; Byron C Yoburn
Journal:  Pharmacol Biochem Behav       Date:  2003-07       Impact factor: 3.533

9.  Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior.

Authors:  Stephen D Mague; Carolina Isiegas; Peng Huang; Lee-Yuan Liu-Chen; Caryn Lerman; Julie A Blendy
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-15       Impact factor: 11.205

10.  Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers.

Authors:  Inge Mick; Jim Myers; Anna C Ramos; Paul R A Stokes; David Erritzoe; Alessandro Colasanti; Roger N Gunn; Eugenii A Rabiner; Graham E Searle; Adam D Waldman; Mark C Parkin; Alan D Brailsford; José C F Galduróz; Henrietta Bowden-Jones; Luke Clark; David J Nutt; Anne R Lingford-Hughes
Journal:  Neuropsychopharmacology       Date:  2015-11-10       Impact factor: 7.853

View more
  9 in total

1.  Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Authors:  Jarkko Johansson; Jussi Hirvonen; Zsófia Lovró; Laura Ekblad; Valtteri Kaasinen; Olli Rajasilta; Semi Helin; Jouni Tuisku; Saija Sirén; Mirka Pennanen; Arvind Agrawal; Roger Crystal; Petri J Vainio; Hannu Alho; Mika Scheinin
Journal:  Neuropsychopharmacology       Date:  2019-03-13       Impact factor: 7.853

Review 2.  Opioid system and human emotions.

Authors:  Lauri Nummenmaa; Lauri Tuominen
Journal:  Br J Pharmacol       Date:  2017-05-24       Impact factor: 8.739

3.  μ-opioid receptor system mediates reward processing in humans.

Authors:  Lauri Nummenmaa; Tiina Saanijoki; Lauri Tuominen; Jussi Hirvonen; Jetro J Tuulari; Pirjo Nuutila; Kari Kalliokoski
Journal:  Nat Commun       Date:  2018-04-16       Impact factor: 14.919

Review 4.  Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

Authors:  Matthieu Colom; Benjamin Vidal; Luc Zimmer
Journal:  Front Mol Neurosci       Date:  2019-10-18       Impact factor: 5.639

5.  Changes of EEG band oscillations to tonic cold pain and the behavioral inhibition and fight-flight-freeze systems.

Authors:  Vilfredo De Pascalis; Paolo Scacchia; Beatrice Papi; Philip J Corr
Journal:  Personal Neurosci       Date:  2019-11-26

6.  Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety.

Authors:  Lauri Nummenmaa; Tomi Karjalainen; Janne Isojärvi; Tatu Kantonen; Jouni Tuisku; Valtteri Kaasinen; Juho Joutsa; Pirjo Nuutila; Kari Kalliokoski; Jussi Hirvonen; Jarmo Hietala; Juha Rinne
Journal:  Neuropsychopharmacology       Date:  2020-05-30       Impact factor: 7.853

7.  μ-opioid receptor availability is associated with sex drive in human males.

Authors:  Lauri Nummenmaa; Patrick Jern; Tuulia Malén; Tatu Kantonen; Laura Pekkarinen; Lasse Lukkarinen; Lihua Sun; Pirjo Nuutila; Vesa Putkinen
Journal:  Cogn Affect Behav Neurosci       Date:  2021-11-22       Impact factor: 3.282

8.  Taking the chance!-Interindividual differences in rule-breaking.

Authors:  Leidy Cubillos-Pinilla; Franziska Emmerling
Journal:  PLoS One       Date:  2022-10-07       Impact factor: 3.752

Review 9.  A Survey of Molecular Imaging of Opioid Receptors.

Authors:  Paul Cumming; János Marton; Tuomas O Lilius; Dag Erlend Olberg; Axel Rominger
Journal:  Molecules       Date:  2019-11-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.